Back to comparisons

Comparison

Rhodiola Rosea vs Honokiol (Magnolia Bark)

FieldRhodiola RoseaHonokiol (Magnolia Bark)
Categoryadaptogenadaptogen
Dose range200–400mg250–1000mg
Half-life4h
Onset
EvidenceEVIDENCEAEVIDENCEB
Safety●●●●●●●●●
Legal (US)USOTCUSOTC
PubMed refs460600

The comparison in plain English

Auto-generated from data

Rhodiola Rosea and Honokiol (Magnolia Bark) are both in the adaptogen category respectively. Rhodiola Rosea An Arctic adaptogen used for centuries in Siberian, Scandinavian, and Tibetan traditional medicine. Honokiol (Magnolia Bark) Bioactive lignan from Magnolia bark.

Bottom line

Rhodiola Rosea (evidence A, safety 5/5) has a weaker evidence base than Honokiol (Magnolia Bark) (evidence B, safety 4/5). Rhodiola Rosea has the slightly cleaner safety profile. For users new to either, the higher-evidence option is the safer first try.

Choose Rhodiola Rosea if

Rhodiola Rosea is the better fit when your goal aligns with its mechanism (Rosavins and salidroside (the two standardised active compounds) modulate the HPA axis cortisol response under acute stress) and the dose range (200–400mg) suits your protocol. Half-life is 4h.

Choose Honokiol (Magnolia Bark) if

Honokiol (Magnolia Bark) is the better fit when your goal aligns with its mechanism (Honokiol and magnolol are positive allosteric modulators of GABA-A receptors at sites distinct from benzodiazepines) and the dose range (250–1000mg) suits your protocol. Half-life is —h.

Build a stack with bothOpen builder →
Check interactionsOpen checker →